Long-COVID postural tachycardia syndrome: an American Autonomic Society statement

被引：0

作者：

Satish R. Raj

Amy C. Arnold

Alexandru Barboi

Victoria E. Claydon

Jacqueline K. Limberg

Vera-Ellen M. Lucci

Mohammed Numan

Amanda Peltier

Howard Snapper

Steven Vernino

机构：

[1] Libin Cardiovascular Institute,Department of Cardiac Sciences

[2] University of Calgary,Division of Clinical Pharmacology, Department of Medicine, Autonomic Dysfunction Center

[3] Vanderbilt University Medical Center,Department of Neural and Behavioral Sciences

[4] Pennsylvania State University College of Medicine,Department of Neurology, NorthShore University Health System, Pritzker School of Medicine

[5] University of Chicago,Department of Biomedical Physiology and Kinesiology

[6] Simon Fraser University,Department of Nutrition and Exercise Physiology

[7] University of Missouri,Division of Cardiology, Department of Pediatrics

[8] University of Texas Health Sciences Center at Houston,Department of Neurology, Autonomic Dysfunction Center

[9] Vanderbilt University Medical Center,Cardiology Division

[10] Wellstar Healthcare System,Department of Neurology

[11] UT Southwestern Medical Center,undefined

来源：

Clinical Autonomic Research | 2021年 / 31卷

关键词：

COVID ; Long COVID; Postural tachycardia syndrome; Position statement;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

COVID-19 is a global pandemic that has had a devastating effect on the health and economy of much of human civilization. While the acute impacts of COVID-19 were the initial focus of concern, it is becoming clear that in the wake of COVID-19, many patients are developing chronic symptoms that have been called Long-COVID. Some of the symptoms and signs include those of postural tachycardia syndrome (POTS). Understanding and managing long-COVID POTS will require a significant infusion of health care resources and a significant additional research investment. In this document from the American Autonomic Society, we outline the scope of the problem, and the resources and research needed to properly address the impact of Long-COVID POTS.

引用

页码：365 / 368

页数：3

共 38 条

[1] Goldstein DS(2020)The possible association between COVID-19 and postural orthostatic tachycardia syndrome Heart Rhythm 11 4302-4304
[2] Kanjwal K(2020)New-onset postural orthostatic tachycardia syndrome following coronavirus disease 2019 infection J Innov Card Rhythm Manag 30 449-451
[3] Jamal S(2020)A case report of postural tachycardia syndrome after COVID-19 Clin Auton Res 30 571-573
[4] Kichloo A(2020)Acute hyperhidrosis and postural tachycardia in a COVID-19 patient Clin Auton Res 36 357-372
[5] Grubb BP(2020)Canadian cardiovascular society position statement on postural orthostatic tachycardia syndrome (POTS) and related disorders of chronic orthostatic intolerance Can J Cardiol 286 438-448
[6] Miglis MG(2019)The face of postural tachycardia syndrome—insights from a large cross-sectional online community-based survey J Intern Med 117 11727-11734
[7] Prieto T(2020)Cell entry mechanisms of SARS-CoV-2 Proc Natl Acad Sci 181 271-280.e8
[8] Shaik R(2020)SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor Cell 21 100274-186
[9] Umapathi T(2020)Hemorrhagic stroke and COVID-19 infection: coincidence or causality? NeurologicalSci 32 179-2868
[10] Poh MQW(2020)Guillain–Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions J Neurol Neurosurg Psychiatry 55 2858-undefined

← 1 2 3 4 →